GGrantIndex
← Leaderboards

Kevin Navin Sheth

Brigham And Women'S Hospital

Google Scholar ↗PubMed ↗ORCID ↗
$17,260,134
Attributed
$39,608,634
Total exposure
11
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $8.2M · FY2018–25
$10M$7.5M$5M$2.5M$0
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$39,608,634 · 11

By mechanism

U01$16,892,253 · 1
R01$11,116,686 · 4
UG3$5,747,701 · 1
U24$5,516,931 · 3
R21$251,313 · 1
R03$83,750 · 1

Top collaborators

Most similar at Brigham And Women'S Hospital

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Stroke”

Research focus

StrokeHospitalsDisabilityAcuteInnovationDesignFutureSuccessRecruitPost StrokePatient PopulationStroke TherapyClinical TrialsMultidisciplinaryEnrollmentCommunitiesCharacteristicsIschemic StrokeAdultMulticenter StudiesResearch Project GrantsCessation Of LifeLeadStroke Patient

Grant awards (45)

Cilostazol for Prevention of Recurrent Stroke (CLARITY)$5,747,701
UG3 · FY2025 · NS
Social networks and risk of delayed arrival to the hospital during stroke$737,315
R01 · FY2025 · MD
Portable, Low Field Brain Magnetic Resonance Imaging (MRI) for Acute Stroke$703,708
R01 · FY2025 · EB · contact PI
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)$399,587
U24 · FY2025 · NS · contact PI
Yale-METRO Metropolitan Emergency Trial netwoRK to advance patient Outcomes$371,900
U24 · FY2025 · NS
Prospective Identification of Hypoxic Ischemic Brain Injury Using Portable Magnetic Resonance Imaging$251,313
R21 · FY2025 · NS
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)$4,840,791
U01 · FY2024 · NS · contact PI
Social networks and risk of delayed arrival to the hospital during stroke$716,072
R01 · FY2024 · MD
Portable, Low Field Brain Magnetic Resonance Imaging (MRI) for Acute Stroke$690,249
R01 · FY2024 · EB · contact PI
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)$494,611
U24 · FY2024 · NS · contact PI
Yale-METRO Metropolitan Emergency Trial netwoRK to advance patient Outcomes$404,274
U24 · FY2024 · NS
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)$4,270,266
U01 · FY2023 · NS · contact PI
Social networks and risk of delayed arrival to the hospital during stroke$739,466
R01 · FY2023 · MD
Portable, Low Field Brain Magnetic Resonance Imaging (MRI) for Acute Stroke$704,334
R01 · FY2023 · EB · contact PI
The Recovery in Stroke Using PAP (RISE UP) Study$642,567
R01 · FY2023 · NR
Yale-METRO Metropolitan Emergency Trial netwoRK to advance patient Outcomes$500,854
U24 · FY2023 · NS
Improved glyburide therapy via acid- triggered release functional nanoparticles and therapeutic imaging$361,070
R01 · FY2023 · NS
Improved glyburide therapy via acid- triggered release functional nanoparticles and therapeutic imaging$13,819
R01 · FY2023 · NS
Social networks and risk of delayed arrival to the hospital during stroke$774,300
R01 · FY2022 · MD
Portable, Low Field Brain Magnetic Resonance Imaging (MRI) for Acute Stroke$744,150
R01 · FY2022 · EB · contact PI
The Recovery in Stroke Using PAP (RISE UP) Study$667,196
R01 · FY2022 · NR
Improved glyburide therapy via acid- triggered release functional nanoparticles and therapeutic imaging$367,550
R01 · FY2022 · NS
Yale Clinical Site: Investigations For Improved Neurological Treatments at Yale (INFINITY)$335,000
U24 · FY2022 · NS · contact PI
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)$327,391
U24 · FY2022 · NS · contact PI
Improved glyburide therapy via acid- triggered release functional nanoparticles and therapeutic imaging$12,563
R01 · FY2022 · NS
The Recovery in Stroke Using PAP (RISE UP) Study$692,823
R01 · FY2021 · NR
Improved glyburide therapy via acid- triggered release functional nanoparticles and therapeutic imaging$367,550
R01 · FY2021 · NS
Yale Clinical Site: Investigations For Improved Neurological Treatments at Yale (INFINITY)$335,000
U24 · FY2021 · NS · contact PI
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)$327,391
U24 · FY2021 · NS · contact PI
Improved glyburide therapy via acid- triggered release functional nanoparticles and therapeutic imaging$23,031
R01 · FY2021 · NS
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)$3,246,233
U01 · FY2020 · NS · contact PI
The Recovery in Stroke Using PAP (RISE UP) Study$692,823
R01 · FY2020 · NR
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)$502,754
U01 · FY2020 · NS · contact PI
Improved glyburide therapy via acid- triggered release functional nanoparticles and therapeutic imaging$371,020
R01 · FY2020 · NS
Yale Clinical Site: Investigations For Improved Neurological Treatments at Yale (INFINITY)$335,000
U24 · FY2020 · NS · contact PI
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)$327,391
U24 · FY2020 · NS · contact PI
Intensive Blood Pressure Reduction in Deep Intracerebral Hemorrhage$41,875
R03 · FY2020 · NS
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)$4,032,209
U01 · FY2019 · NS · contact PI
The Recovery in Stroke Using PAP (RISE UP) Study$716,235
R01 · FY2019 · NR
Improved glyburide therapy via acid- triggered release functional nanoparticles and therapeutic imaging$378,845
R01 · FY2019 · NS
Yale Clinical Site: Investigations For Improved Neurological Treatments at Yale (INFINITY)$335,000
U24 · FY2019 · NS · contact PI
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)$327,391
U24 · FY2019 · NS · contact PI
Intensive Blood Pressure Reduction in Deep Intracerebral Hemorrhage$41,875
R03 · FY2019 · NS
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)$361,141
U24 · FY2018 · NS · contact PI
Yale Clinical Site: Investigations For Improved Neurological Treatments at Yale (INFINITY)$335,000
U24 · FY2018 · NS · contact PI